Projected incremental cost effectiveness per Ng/Ct or HIV infection averted (for 1995–8 and in 2004 $US) of using POC tests (of different sensitivities) instead of the syndromic approach in the SIDA2 project in Cotonou
| Sensitivity of POC test | Incremental cost effectiveness per Ng/Ct infection averted | Incremental cost effectiveness per HIV infection averted | ||||||
|---|---|---|---|---|---|---|---|---|
| $1 per test | $2 per test | $3 per test | $4 per test | $1 per test | $2 per test | $3 per test | $4 per test | |
| Numbers in parentheses are uncertainty bounds. | ||||||||
| 50% | 16.0 (14.3–17.7) | 30.5 (27.3–33.8) | 45.0 (40.2–50.0) | 59.6 (53.2–66.1) | 830.8 (640.7–1355.8) | 1586.8 (1223.7–2589.7) | 2342.9 (1806.7–3823.5) | 3099.0 (2389.7–5057.3) |
| 60% | 2.8 (2.5–3.1) | 5.2 (4.6–5.8) | 7.7 (6.8–8.5) | 10.1 (9.0–11.2) | 143.6 (110.4–232.9) | 271.1 (208.5–439.7) | 398.6 (306.5–646.6) | 526.2 (404.6–853.4) |
| 70% | 1.6 (1.4–1.7) | 2.9 (2.6–3.2) | 4.3 (3.8–4.7) | 5.6 (5.0–6.3) | 81.0 (62.3–131.1) | 151.4 (116.5–244.9) | 221.8 (170.6–358.8) | 292.2 (224.7–472.6) |
| 80% | 1.1 (1.0–1.2) | 2.0 (1.8–2.3) | 3.0 (2.6–3.3) | 3.9 (3.5–4.4) | 57.6 (44.2–92.8) | 106.6 (81.9–171.9) | 155.5 (119.6–250.9) | 204.5 (157.2–329.9) |